BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 30005287)

  • 1. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
    Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Albumin-Based Delivery System Generated by Programmed Assembly for Tumor-Targeted Multimodal Therapy and Imaging.
    Xu L; Wang SB; Xu C; Han D; Ren XH; Zhang XZ; Cheng SX
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38385-38394. PubMed ID: 31556589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinspired DNA nanocockleburs for targeted delivery of doxorubicin.
    Sun S; Cheraga N; Jiang HN; Xiao QR; Gao PC; Wang Y; Wei YY; Wang XW; Jiang Y
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110733. PubMed ID: 31864113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
    Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
    Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Delivery.
    Yang L; Sun H; Liu Y; Hou W; Yang Y; Cai R; Cui C; Zhang P; Pan X; Li X; Li L; Sumerlin BS; Tan W
    Angew Chem Int Ed Engl; 2018 Dec; 57(52):17048-17052. PubMed ID: 30387923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BSA-based Cu
    Liu Z; Chan L; Ye X; Bai Y; Chen T
    Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
    Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.